A detailed history of Atria Investments LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 2,645 shares of BIO stock, worth $876,526. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,645
Previous 2,422 9.21%
Holding current value
$876,526
Previous $661,000 33.74%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$263.97 - $344.64 $58,865 - $76,854
223 Added 9.21%
2,645 $884,000
Q2 2024

Aug 13, 2024

BUY
$268.26 - $339.48 $649,725 - $822,220
2,422 New
2,422 $661,000
Q1 2020

May 15, 2020

BUY
$320.01 - $409.07 $79,042 - $101,040
247 Added 27.11%
1,158 $406,000
Q4 2019

Feb 11, 2020

BUY
$319.73 - $374.2 $291,274 - $340,896
911 New
911 $337,000
Q4 2018

Feb 12, 2019

SELL
$220.1 - $309.0 $237,047 - $332,793
-1,077 Closed
0 $0
Q3 2018

Oct 09, 2018

BUY
$289.28 - $326.15 $311,554 - $351,263
1,077 New
1,077 $337,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.16B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.